Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gefitinib”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00068653
What this trial is testing

Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 27
Testing effectiveness (Phase 2)Ended earlyNCT00169221
What this trial is testing

Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas

Who this might be right for
Head and Neck Cancer
Groupe Oncologie Radiotherapie Tete et Cou 54
Not applicableStudy completedNCT01448187
What this trial is testing

Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa

Who this might be right for
Lung Cancer
AstraZeneca 361
Post-approval studies (Phase 4)Study completedNCT01000740
What this trial is testing

A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 59
Testing effectiveness (Phase 2)Study completedNCT00054691
What this trial is testing

ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin

Who this might be right for
Skin Cancer
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT00087334
What this trial is testing

Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)Study completedNCT01530334
What this trial is testing

Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous Treatment

Who this might be right for
Lung Cancer
AstraZeneca 61
Testing effectiveness (Phase 2)Study completedNCT00025142
What this trial is testing

Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

Who this might be right for
Colorectal Cancer
Stanford University
Large-scale testing (Phase 3)Study completedNCT00656136
What this trial is testing

BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 585
Large-scale testing (Phase 3)Ended earlyNCT02588261
What this trial is testing

ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Astellas Pharma Global Development, Inc. 530
Testing effectiveness (Phase 2)Study completedNCT02447419
What this trial is testing

Study to Evaluate the Safety and Efficacy of Gefitinib, in Subjects With EFGR Amplification Refractory Solid Tumors

Who this might be right for
Solid Tumor
Samsung Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT00025675
What this trial is testing

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 105
Testing effectiveness (Phase 2)Study completedNCT00250887
What this trial is testing

Pre- and Postoperative Use of ZD1839 (Iressa) in Recurrent Glioblastoma, Including Translational Research

Who this might be right for
Recurrent Glioblastoma
University of Zurich 22
Testing effectiveness (Phase 2)Study completedNCT02025114
What this trial is testing

Selumetinib in Combination With Gefitinib in NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
National Taiwan University Hospital 34
Not applicableStudy completedNCT00091247
What this trial is testing

Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 130
Large-scale testing (Phase 3)Ended earlyNCT00091156
What this trial is testing

Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 598
Large-scale testing (Phase 3)Study completedNCT00357734
What this trial is testing

Iressa Follow-up Trial

Who this might be right for
Lung CancerBreast Cancer
AstraZeneca 14
Testing effectiveness (Phase 2)Study completedNCT00014170
What this trial is testing

Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 92
Testing effectiveness (Phase 2)Study completedNCT00239291
What this trial is testing

Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer

Who this might be right for
Non-Metastatic Prostate Cancer
AstraZeneca 42
Testing effectiveness (Phase 2)Study completedNCT00787410
What this trial is testing

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma

Who this might be right for
Mesothelioma
AstraZeneca 23
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation